WA
BNTX icon

Whipplewood Advisors’s BioNTech BNTX Stock Holding History

Whipplewood Advisors’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-7
Closed -$745 – 407
2025
Q2 		$745 Sell
7
-7
-50% -$707 ﹤0.01% 1066
2025
Q1 		$1.82K Sell
14
-71
-84% -$7.95K ﹤0.01% 907
2024
Q4 		$9.69K Buy
+85
New +$9.7K 0.01% 559

Other funds holding BNTX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Whipplewood Advisors's BNTX Position: Q3 2025 in Review

Whipplewood Advisors sold out of BioNTech (BNTX) in Q3 2025, closing a stake of 7 shares — an estimated $745 sold.

Whipplewood Advisors first reported a position in BNTX in Q4 2024 and held it in 3 quarters. The position peaked at $9.69K in Q4 2024. 254 funds tracked by Wall St. Rank hold BNTX as of Q3 2025.

  • Whipplewood Advisors reported no remaining BioNTech position as of Q3 2025 after selling out during the quarter.
  • Whipplewood Advisors sold 7 BioNTech shares in Q3 2025, an estimated $745.
  • Whipplewood Advisors first reported a position in BioNTech in Q4 2024 and held it in 3 quarters.
  • Whipplewood Advisors's BioNTech position peaked at $9.69K in Q4 2024.
  • 254 funds tracked by Wall St. Rank held BioNTech as of Q3 2025.

Based on Whipplewood Advisors's 13F filing for Q3 2025, filed 6 Nov 2025.